SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Headlines > Downstream Processing

GEA and Siemens team on continuous processing tech

17-Jan-2017 - Siemens and GEA have developed a continuous manufacturing platform for pharmaceuticals that integrates the former’s quality control software.

Strategic partnership forms single-source solution for biopharma

10-Jan-2017 - CSSi LifeSciences and BioMARC have announced a strategic partnership to provide 'fully cohesive product development and support' for vaccine and biologic development. 

COLD CHAIN

Cryoport to deliver Gradalis autologus immuno-oncology therapies across US

05-Jan-2017 - Cryoport’s network of cold chain logistics will support the delivery of Gradalis Inc’s autologous cell therapy to various cancer trial sites across the US.

Prokarium and Probiomed team to scale-up thermostable oral vaccine

04-Jan-2017 - The project funded by the UK and Mexican governments will look to prove the scalability of Prokarium’s oral vaccine platform, the firm says.

Repligen adds single-use filtration tech through TangenX acquisition

20-Dec-2016 - Repligen has bought Novasep subsidiary TangenX Technology for $39m, adding single-use tangential flow filtration (TFF) cassettes to its downstream offering.

apceth Biopharma joins Lonza as bluebird bio cell therapy contractor

15-Dec-2016 - bluebird bio Inc has hired apceth Biopharma GmbH to make its candidate ALD cell therapy Lenti-D and its thalassemia treatment LentiGlobin for the European market.

BMS reshuffles US operations with multiple R&D closures and construction

14-Dec-2016 - Bristol-Myers Squibb has announced plans to pull the plug on some US facilities and streamline construction and investment around “vibrant academic ecosystems”. 

Growth in biologics and vaccines leading injectables business, Aptar Pharma

12-Dec-2016 - Aptar Pharma is nearing completion of its US-based manufacturing site, as it continues to expand globally to keep pace with growth in the injectable drug delivery industry.

Sanofi and Merck & Co team with Natrix on 'truly disposable' Protein A platform

07-Dec-2016 - Sanofi, Merck & Co. and downstream technology firm Natrix have teamed to develop a chromatography system with a productivity level capable to enable a fully-integrated downstream platform.

GSK extends single-use purification tech R&D deal with Puridify

06-Dec-2016 - The development partnership has been extended as GlaxoSmithKline looks to make clinical trial scale batches using Puridify’s Protein A alternative to packed bed chromatography columns.

Cook and Asymptote to launch water-free automated cell thawing tech

30-Nov-2016 - An automated system co-developed with Cook Regenetec offers a more controlled and repeatable method of thawing cell and gene therapies than traditional techniques, says Asymptote.

Complexity of new logistics policy may stunt China vaccine industry, Sinovac

29-Nov-2016 - Sinovac’s vaccine sales recovered in Q3 after it restarted activities halted while it brought operations into line with new Chinese distribution regulations.

Cold chain challenges evolving with industry, Cryoport

23-Nov-2016 - While the temperature is dropping outside, keeping clinical trial therapeutics and biospecimens at the right temperature during transportation is a challenge year-round.

Lyophilised biologic reconstitution IP up for grabs after XstalBio folds

22-Nov-2016 - A technology developed to reduce time and increase safety when reconstituting lyophilised biologics has been put for up for sale after XstalBio's insolvency.

Novasep eyes Japan's bioprocessing market with chromatography BD contract

18-Nov-2016 - Novasep has expanded a partnership with AR Brown to supply its chromatography equipment to Japanese biomanufacturers.

Repligen: resin recovery feature a ‘differentiator’ in chromatography space

08-Nov-2016 - A resin recovery feature being added to its larger prefilled chromatography columns offers an ‘insurance policy’ for drugmakers, says Repligen.

Shire closing US plant as it begins to assess post-Baxalta manufacturing footprint

04-Nov-2016 - Shire says it is closing a plasma fractionating facility in Los Angeles, US but remains positive it can successfully manage its post-Baxalta manufacturing network of 17 sites.

Sanofi and Regeneron mull FDA CRL after fill/finish plant hit with 483

31-Oct-2016 - The US FDA has issued a complete response letter for Sanofi and Regeneron’s rheumatoid arthritis candidate sarilumab due to manufacturing deficiencies at a fill/finish plant in France.

Samsung Bioepis contracts Catalent to help commercialize Benepali

19-Oct-2016 - Samsung Bioepis has contracted Catalent to provide fill finish services for its Enbrel (etanercept) biosimilar, Benepali.

Danaher set to buy purification consumables firm Phenomenex

12-Oct-2016 - Danaher Corporation will further extend its presence in the life sciences space through the acquisition of separations and purification firm Phenomenex.

Industry recognises continuous downstream tech at CPhI and Biotech Week

07-Oct-2016 - The conservatism of the biotech industry held back adoption of continuous manufacturing tech but this is now changing says Novasep, winner of the CPhI bioprocessing award.

BPI Boston

Continuous bioprocessing next logical step after single-use adoption, Pall

06-Oct-2016 - The strong adoption of single-use technology is enabling industry to transition towards continuous bioprocessing systems, says Pall Corporation.

Sartorius Stedim Biotech adds PESU membranes to benchtop filtration techs

04-Oct-2016 - Sartorius Stedim Biotech (SSB) claims benchtop vaccine and protein purification techs could save developers €2000 per batch and reduce processing time by 60%.

Lonza expands cell and gene therapy plant it is building in Texas

30-Sep-2016 - The cell and gene therapy plant Lonza is building in Pearland, Texas will be bigger than originally planned to according to the city’s economic development corporation.

Innova launches 'conjugation compatible' antibody purification system

21-Sep-2016 - Innova Biosciences says its AbPure Protein A-based system removes the need to undergo an additional step when purifying antibody in preparation for conjugation

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...